期刊
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
卷 143, 期 7, 页码 1107-1122出版社
SPRINGER
DOI: 10.1007/s00432-016-2325-y
关键词
Breast cancer; Vitamin D; Vitamin D receptor; Estrogen receptor; HER2
类别
资金
- China Scholarship Council (CSC) [201508080093]
- University Paul Sabatier in Toulouse (France)
Breast cancer is a significant global public health issue. It is the leading cause of death among women around the world, with an incidence increasing annually. In recent years, there has been more and more information in the literature regarding a protective role of vitamin D in cancer. Increasingly preclinical and clinical studies suggest that vitamin D optimal levels can reduce the risk of breast cancer development and regulate cancer-related pathways. In this review, we focus on the importance of vitamin D in breast cancers, discussing especially the influence of vitamin D signaling on estrogen receptor and human epidermal growth factor receptor 2 (HER2), two major biomarkers of breast cancer today. We discuss the possibility of actual and future targeted therapeutic approaches for vitamin D signaling in breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据